David Dangoor

Title: David Dangoor: Innovator in Neuroprotective Therapies

Introduction

David Dangoor is a prominent inventor based in Netanya, Israel. He has made significant contributions to the field of neuroprotective therapies, particularly through his innovative research and patent in this area. His work focuses on the dynamics of tau and microtubules, which are crucial for neuronal health.

Latest Patents

David Dangoor holds a patent for "Therapeutics based on tau/microtubule dynamics." This invention is based on the discovery of a novel neuroprotective peptide known as NAP. The NAP peptide enhances the association of tau with the brain-specific beta tubulin subunit. Furthermore, NAP modifies microtubule assembly and dynamics by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for the treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, and NAP-like tau peptide mimetics. He has 1 patent to his name.

Career Highlights

David Dangoor is affiliated with Tel Aviv University, where he continues to advance his research in neuroprotective therapies. His work has garnered attention for its potential impact on treating various neuronal disorders.

Collaborations

David collaborates with notable colleagues, including Illana Gozes and Maya Maor, who contribute to his research endeavors.

Conclusion

David Dangoor is a key figure in the development of neuroprotective therapies, with a focus on tau and microtubule dynamics. His innovative work holds promise for the treatment of neuronal disorders, showcasing the importance of research in this critical field.